Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryli E. Justice
Observed name:
Ryli Justice
Institution:
Indiana University School of Medicine
Observed institutions:
Indiana University Health,
Indiana University Indianapolis,
Indiana University Melvin and Bren Simon Comprehensive Cancer Center,
Indiana University School of Medicine
ORCID:
0000-0002-2378-2688
Observed ORCID:
0000-0002-2378-2688
OpenAlex ID:
A5006494158
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors
2022
·
Pankita H. Pandya
, Asha Jacob Jannu
, et al.
·
Cancers
·
18
PDF
Dual CDK4/6–PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma
2026
·
Farinaz Barghi
, M. Reza Saadatzadeh
, et al.
·
Neoplasia
·
6
Therapeutic Targeting of BET Proteins in Sarcoma
2025
·
Niknam Riyahi
, Rada Malko
, et al.
·
Molecular Cancer Therapeutics
·
2
Abstract 5340: Simultaneous targeting of CDK4/6 and BETs is independent of RB status in osteosarcoma
2025
·
Rada Malko
, Pankita H. Pandya
, et al.
·
Cancer Research
·
1
Abstract 6728: Osteosarcoma patient-derived xenografts derived from naive and pretreated metastatic patients with high-risk CDK4/6 hyperactivation signatures are sensitive to dual inhibition of CDK4/6 and PI3K/mTOR
2023
·
Farinaz Barghi
, M. Reza Saadatzadeh
, et al.
·
Cancer Research
·
1
Abstract 6017: BET inhibition potentiates salvage chemotherapy response through TXNIP upregulation in osteosarcoma
2026
·
Keiko E. Kreklau
, Niknam Riyahi
, et al.
·
Cancer Research
Abstract 6483: Convergent CDK4/6 and PI3K/mTOR pathway hyperactivation defines a targetable axis in osteosarcoma across RB1-proficient and RB1-deficient contexts
2026
·
Lauren K. Stevens
, M. Reza Saadatzadeh
, et al.
·
Cancer Research
Abstract 7045: Anti-tumor effects following BET inhibition in preclinical models of pediatric and AYA osteosarcoma
2025
·
Ryli E. Justice
, Niknam Riyahi
, et al.
·
Cancer Research
Abstract 5719: Targeting CDK4/6 and BET proteins for the treatment of RB+ and RB- osteosarcoma
2024
·
Rada Malko
, Pankita H. Pandya
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
28
H-index:
2
I10-index:
1
Year
Topic
Type